home / stock / zen:cc / zen:cc news


ZEN:CC News and Press, Zentek Ltd. From 01/22/24

Stock Information

Company Name: Zentek Ltd.
Stock Symbol: ZEN:CC
Market: TSXVC
Website: zentek.com

Menu

ZEN:CC ZEN:CC Quote ZEN:CC Short ZEN:CC News ZEN:CC Articles ZEN:CC Message Board
Get ZEN:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

ZEN:CC - Zentek Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters

GUELPH, ON / ACCESSWIRE / January 22, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce the completion of a new study highlighting the potential significant energy, emission and ...

ZEN:CC - Zentek Announces Eric Wallman Appointed as Chairman of the Board

GUELPH, ON / ACCESSWIRE / January 19, 2024 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces that effective January 12th, Dr. Francis Dubé has resigned as Chairman of the Board of the Company...

ZEN:CC - Zentek Launches Triera Biosciences Ltd.

GUELPH, ON / ACCESSWIRE / December 13, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company announces the launch of Triera Biosciences Ltd. (Triera) as Zentek's wholly owned subsidiary for its a...

ZEN:CC - Zentek and 1Click Heating and Cooling Sign Distribution Agreement

GUELPH, ON / ACCESSWIRE / December 8, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company and 1Click Heating and Cooling Inc. ("1Click"), a private Heating, Ventilation and Air Conditioning ("HVAC") compa...

ZEN:CC - Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant

GUELPH, ON / ACCESSWIRE / November 29, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company announces successful testing of its COVID-19 High-Binding Affinity (C19HBA) aptamer against the Omicro...

ZEN:CC - Zentek Announces Update on the Albany Graphite Project

GUELPH, ON / ACCESSWIRE / November 21, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company provides an update on its wholly owned subsidiary Albany Graphite Corp. On April 25 th , 2023, Zentek announced t...

ZEN:CC - Zentek Reports Improvements and Expansion of its Aptamer-Based Platform Technology

GUELPH, ON / ACCESSWIRE / November 15, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company announces the development of a significant upgrade to its aptamer platform improving the binding affin...

ZEN:CC - Expected Canadian Company Earnings on Monday, November 13th, 2023

Fission Uranium Corp. (FCU:CA) is expected to report for Q1 2024 Power Corporation of Canada Subordinate Voting Shares (POW:CA) is expected to report $1 for Q3 2023 Spark Power Group Inc. (SPG:CA) is expected to report for Q1 2024 ECN Capital Corp. (ECN:CA) is expected to report $0.02...

ZEN:CC - Zentek Completes Return on Investment Analysis for Canadian Healthcare System

GUELPH, ON / ACCESSWIRE / October 17, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company is pleased to announce completion of a study on the potential savings for the Canadian healthcare system from adoptin...

ZEN:CC - Zentek Announces Successful Aptamer Testing for Longevity of Protection and Minimum Effective Dose

GUELPH, ON / ACCESSWIRE / October 10, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to announce further successful pre-clinical testing of the aptamer-based platform technology...

Previous 10 Next 10